Customize
Quick Links
Specialties

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Celgene Corporation, Incyte Corporation, and PharmaEssentia USA.

Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis


Release Date: February 28, 2019
Expiration Date: February 28, 2020
Media: Internet - based

Activity Overview

We are pleased to present this CME-certified activity, a PER® Live Virtual Tumor Board®: Advancing Polycythemia Vera and Myelofibrosis Enduring CME Activity. This activity is an enduring version of the live Virtual Tumor Board® originally presented by PER® at www.gotoper.com on February 21, 2019, at 8:00 PM EST.

This program explores current trends in the prognostic scoring, molecular diagnostic studies, and appropriate guideline-based management of myeloproliferative neoplasms (MPNs), as well as current and emerging therapeutic strategies across MPNs. By applying evidence in real-world case scenarios, this program contextualizes that evidence to ensure that practitioners are up-to-date with recent developments in molecular diagnostics, the effect of diagnostic techniques on therapeutic decision-making, current clinical trial findings, evolving treatment paradigms, and the mechanistic rationale for novel therapeutic approaches in the context of MPN pathophysiology.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Celgene Corporation, Incyte Corporation, and PharmaEssentia USA.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, educational content/audio files will be available for your reference.
  • In order to receive a CME certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME certificate upon completion of these steps.


Target Audience

This educational activity is directed toward hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with MPNs. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of MPNs may also participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  1. Discuss recent developments in molecular diagnostics and their impact on therapeutic decision-making in the management of myelofibrosis (MF) and polycythemia vera (PV)
  2. Describe the mechanistic rationale for overlap of MF and PV therapeutic approaches in the context of the current treatment landscape
  3. Evaluate clinical trial data on emerging agents and regimens to treat MF and PV
  4. Integrate recent trial findings to optimize clinical decision-making and care for patients with MF and PV

Faculty, Staff, and Planners' Disclosures

Faculty

Ronald Hoffman, MD
Albert A. and Vera G. List Professor of Medicine
Director, Myeloproliferative Disorders Research Program
The Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY

Disclosures: Grant/Research Support: Merus, Forbius, Incyte, Elstar, Scholar Rock, Novartis; Consultant: Novartis, La Jolla Pharmaceuticals

Abdulraheem Yacoub, MD
Associate Professor of Medicine
University of Kansas Cancer Center
Kansas City, KS
 
 

Disclosures: Consultant and Speakers Bureau: Incyte Pharma

Gillian Sanchez, MPH, BSN, RN
Clinical Research Program Manager
Adult Leukemia Program
The Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY

Disclosures: Registered Nurse Gillian Sanchez has no relevant financial relationships with commercial interests to disclose.

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

 

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any of the companies that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields






Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
31
Filter By